Peptide Associates Announces New Era in Peptide Innovation with GLP-3/Triple G Injection Offering
Sarasota, Florida – 25 May 2026 – Peptide Associates today announced the expansion of its peptide wellness portfolio through the introduction of its GLP-3/Triple G Injection Offering, a new initiative designed to support the evolving needs of modern wellness consumers seeking structured metabolic support and professionally guided wellness solutions. The announcement marks another milestone in […] Continue Reading

